Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for vitamin root_names_name in Any Name (approximate match)

Showing 1271 - 1280 of 7705 results

First page
Previous page
Next page
Next page

Bisphenol A diallyl ether

P47L73LDF8

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ACHIRAL)

4-(8-Amino-3-(pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide, (S)-

L7Y5ZXY8SP

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

SITAGLIPTIN DIMER

Q36HRH72XU

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

4-HYDROXY-2-(3-METHOXYPROPYL)-3,4-DIHYDRO-2H-THIENO(3,2-E)(1,2)THIAZINE-6-SULFONAMIDE 1,1-DIOXIDE, (S)-

KCH6847QC4

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

Xanthommatin

3BMW3J9GSZ

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (RACEMIC)

(2S,5S)-3,6-Dioxo-2,5-piperazinediacetamide

ZXY77KXZ8W

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

DIGITOXIGENIN MONO-.BETA.-D-DIGITOXOSIDE

R83CK7MGW3

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

2-(4-NITROPHENYL)IMIDAZO(2,1-A)ISOQUINOLINE

SDE8CNR4WH

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ACHIRAL)

HS-173

2758X982JL

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

PI3-kinase p110-alpha subunit

Conditions:

HS-173 is a potent PI3Kα inhibitor with IC50 of 0.8 nM. HS-173 inhibited the PI3K signaling pathway, and showed anti-proliferative effects on cancer cells. Also, HS-173 induced cell cycle arrest at the G(2)/M phase and apoptosis. In addition, HS-173 decreased the expression HIF-1α and VEGF which play an important role in angiogenesis. This effect was confirmed by the suppression of tube formation and migration assay in vitro. Furthermore, HS-173 diminished blood vessel formation in the Matrigel plug assay in mice. Therefore, HS-173 is considered as a novel drug candidate to treat cancer patients.

2-ETHYL-4-PHENYL-6H-THIENO(3,2-F)(1,2,4)TRIAZOLO(4,3-A)(1,4)DIAZEPINE

HED56F543A

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ACHIRAL)

Structure of Bisphenol A diallyl ether

ACHIRAL

Bisphenol A diallyl ether

Structure of 4-(8-Amino-3-(pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide, (S)-

ABSOLUTE

4-(8-Amino-3-(pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide, (S)-

Structure of SITAGLIPTIN DIMER

ABSOLUTE

SITAGLIPTIN DIMER

Structure of 4-HYDROXY-2-(3-METHOXYPROPYL)-3,4-DIHYDRO-2H-THIENO(3,2-E)(1,2)THIAZINE-6-SULFONAMIDE 1,1-DIOXIDE, (S)-

ABSOLUTE

4-HYDROXY-2-(3-METHOXYPROPYL)-3,4-DIHYDRO-2H-THIENO(3,2-E)(1,2)THIAZINE-6-SULFONAMIDE 1,1-DIOXIDE, (S)-

Structure of Xanthommatin

RACEMIC

Structure of (2S,5S)-3,6-Dioxo-2,5-piperazinediacetamide

ABSOLUTE

(2S,5S)-3,6-Dioxo-2,5-piperazinediacetamide

Structure of DIGITOXIGENIN MONO-.BETA.-D-DIGITOXOSIDE

ABSOLUTE

DIGITOXIGENIN MONO-.BETA.-D-DIGITOXOSIDE

Structure of 2-(4-NITROPHENYL)IMIDAZO(2,1-A)ISOQUINOLINE

ACHIRAL

2-(4-NITROPHENYL)IMIDAZO(2,1-A)ISOQUINOLINE

Structure of HS-173

ACHIRAL

Structure of 2-ETHYL-4-PHENYL-6H-THIENO(3,2-F)(1,2,4)TRIAZOLO(4,3-A)(1,4)DIAZEPINE

ACHIRAL

2-ETHYL-4-PHENYL-6H-THIENO(3,2-F)(1,2,4)TRIAZOLO(4,3-A)(1,4)DIAZEPINE

Showing 1271 - 1280 of 7705 results

First page
Previous page
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1